DK297385D0 - Carbapenemer med externt alkyleret mono- eller bicyclisk heteroarylalkylthiosubstituent samt laegemiddel indeholdende saadanne forbindelser - Google Patents

Carbapenemer med externt alkyleret mono- eller bicyclisk heteroarylalkylthiosubstituent samt laegemiddel indeholdende saadanne forbindelser

Info

Publication number
DK297385D0
DK297385D0 DK297385A DK297385A DK297385D0 DK 297385 D0 DK297385 D0 DK 297385D0 DK 297385 A DK297385 A DK 297385A DK 297385 A DK297385 A DK 297385A DK 297385 D0 DK297385 D0 DK 297385D0
Authority
DK
Denmark
Prior art keywords
carbapenems
mono
bicyclic
heteroarylalkylthios
alkyled
Prior art date
Application number
DK297385A
Other languages
English (en)
Other versions
DK297385A (da
Inventor
Burton G Christensen
David B R Johnston
Susan M Schmitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK297385D0 publication Critical patent/DK297385D0/da
Publication of DK297385A publication Critical patent/DK297385A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
DK297385A 1984-07-02 1985-07-01 Carbapenemer med externt alkyleret mono- eller bicyclisk heteroarylalkylthiosubstituent samt laegemiddel indeholdende saadanne forbindelser DK297385A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62657984A 1984-07-02 1984-07-02

Publications (2)

Publication Number Publication Date
DK297385D0 true DK297385D0 (da) 1985-07-01
DK297385A DK297385A (da) 1986-03-14

Family

ID=24510989

Family Applications (1)

Application Number Title Priority Date Filing Date
DK297385A DK297385A (da) 1984-07-02 1985-07-01 Carbapenemer med externt alkyleret mono- eller bicyclisk heteroarylalkylthiosubstituent samt laegemiddel indeholdende saadanne forbindelser

Country Status (7)

Country Link
EP (1) EP0167139B1 (da)
JP (1) JPS6163678A (da)
AT (1) ATE61057T1 (da)
CA (1) CA1273011A (da)
DE (1) DE3581847D1 (da)
DK (1) DK297385A (da)
ES (1) ES8609337A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339860C (en) * 1985-06-17 1998-05-12 Tsunehiko Soga Derivatives of penem
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
DE68919508T2 (de) * 1988-04-01 1995-07-20 Sankyo Co 2-(Heterocyclylthio)carbapenemderivate, deren Herstellung und deren Verwendung als Antibiotika.
JP2752143B2 (ja) * 1988-04-01 1998-05-18 三共株式会社 カルバペネム誘導体
US5242914A (en) * 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
WO1991000864A1 (en) * 1989-07-07 1991-01-24 Banyu Pharmaceutical Co., Ltd. Carbapenem derivatives
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
FI119756B (fi) 1995-01-18 2009-03-13 Alteon Inc Tiatsoliumyhdisteiden käyttö pitkälle edenneen glykosylaation lopputuotteiden muodostumisen estossa ja suunnan muutoksessa
BR9607598B1 (pt) * 1995-01-18 2009-05-05 composição farmacêutica, composição tópica, composição ocular e composto.
US5656261A (en) 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
DE19840943A1 (de) 1998-09-08 2000-03-09 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von Derivaten des 4-Alkylsulfinylmethylarylenmethanols
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US20050014747A1 (en) 2003-04-18 2005-01-20 Emily Reinhard Dihydrothiazine prodrugs of thiazolium agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR244550A1 (es) * 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
NZ205626A (en) * 1982-09-28 1986-12-05 Bristol Myers Co Carbapenem antibiotics
ZA836966B (en) * 1982-09-28 1984-04-25 Bristol Myers Co Carbapenem antibiotics

Also Published As

Publication number Publication date
ES8609337A1 (es) 1986-09-01
CA1273011A (en) 1990-08-21
DK297385A (da) 1986-03-14
EP0167139A1 (en) 1986-01-08
EP0167139B1 (en) 1991-02-27
ATE61057T1 (de) 1991-03-15
JPS6163678A (ja) 1986-04-01
DE3581847D1 (de) 1991-04-04
ES544752A0 (es) 1986-09-01

Similar Documents

Publication Publication Date Title
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
DK297385D0 (da) Carbapenemer med externt alkyleret mono- eller bicyclisk heteroarylalkylthiosubstituent samt laegemiddel indeholdende saadanne forbindelser
EP0385517A3 (en) Medicaments for the treatment of emesis
OA09036A (en) Substituted flavonoid compounds, their salts, their manufacture and medecines containing these materials.
AU7194991A (en) Macrolide pharmaceutical solutions
ES8609336A1 (es) Un procedimiento para la preparacion de -1-metilcarbapenems.
NZ211065A (en) The use of quinolyloxy-containing compounds as phytotoxicity antidotes for fenoxaprop-ethyl
AU6307586A (en) Quinoline derivatives
EP0177940A3 (en) Hydrazine derivatives and their use
IL118368A0 (en) N-oxide heteroaroyl derivatives
DK297485A (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
DE3789720D1 (de) Cephalosporinverbindungen.
ES8403108A1 (es) Un procedimiento para preparar azetidinas.
DE3876712D1 (de) Antianaerobe naphthyridinverbindungen.
AP8800109A0 (en) "Heterocyclic insecticides".
NO863616D0 (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidino-thiazolo-4-yl-methylthio)-propionamid.
AU570070B2 (en) Dibromobenzylcyclohexylamine compounds for the treatment of infections
NO910309D0 (no) Fremgangsmaate for fremstilling samt anvedelse av et nytt antibiotisk deoksymulundocandin.
AU5838080A (en) Crystallised cephalosporin salts
GR3004095T3 (da)
DE3588208D1 (de) Cephalosporinderivative
PT83141B (en) Process for the preparation of 3,7-disubstituted-3-cephem compounds useful as antimicrobial agents
DE3579169D1 (de) Herstellung chlorierter polyolefine.
AU569603C (en) Naphthyridine antibacterial compounds
ATE40366T1 (de) Antibakterielle naphthyridin- verbindungen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment